← Open Payments lookup

NICKY NGUYEN: Open Payments

NPI 1861195547 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,186 in 116 payments from 38 companies in 2025. Trend: 2023 $2,988 · 2024 $4,524 · 2025 $3,186

Food & beverage: $2,859Education: $327
CompanyPaymentsAmount
Janssen Biotech, Inc.15$549
AstraZeneca Pharmaceuticals LP11$335
Merck Sharp & Dohme LLC12$288
ABBVIE INC.6$229
Astellas Pharma US Inc9$185
Bayer Healthcare Pharmaceuticals Inc.4$176
Novartis Pharmaceuticals Corporation4$116
Lilly USA, LLC6$115
Agios Pharmaceuticals, Inc.2$86
GlaxoSmithKline, LLC.3$83

Products named: KEYTRUDA, VENCLEXTA, TECVAYLI, Nubeqa, RYBREVANT, DARZALEX, VERZENIO, ENHERTU.

Industry payments across TX — which companies pay providers there.